InsiderTrades

Form 4 for AMD Advanced Micro Devices

Accepted 2021-11-12 00:00:00 ET · period of report 2021-11-09 · accession 0000002488-21-000189 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2021-11-12 2021-11-09 AMD Su Lisa T Pres, CEO, Dir S - Sale+OE $148.66 -125.0K 2.28M -5% -$18.58M
D 2021-11-12 2021-11-09 AMD Su Lisa T Pres, CEO, Dir M - OptEx $2.92 +125.0K 2.28M +6% +$365.0K
D 2021-11-12 2021-11-09 AMD Su Lisa T Pres, CEO, Dir M - OptEx $0.00 -125.0K 878.5K -12% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-11-09 S D 1,900 $154.24 2,159,150 D — — (F3) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 4, 2020. (F13) Transaction executed in multiple trades at prices ranging from $153.54 to $154.53 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
2 Common Common Stock 2021-11-09 S D 1,000 $155.08 2,158,150 D — — (F3) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 4, 2020. (F14) Transaction executed in multiple trades at prices ranging from $154.60 to $155.54 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
3 Common Common Stock 2021-11-09 S D 2,643 $152.90 2,161,050 D — — (F3) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 4, 2020. (F12) Transaction executed in multiple trades at prices ranging from $152.53 to $153.49 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
4 Common Common Stock 2021-11-09 S D 4,502 $152.08 2,163,693 D — — (F3) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 4, 2020. (F11) Transaction executed in multiple trades at prices ranging from $151.52 to $152.51 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
5 Common Common Stock 2021-11-09 S D 2,800 $150.86 2,168,195 D — — (F3) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 4, 2020. (F10) Transaction executed in multiple trades at prices ranging from $150.46 to $151.41 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
6 Common Common Stock 2021-11-09 S D 3,800 $149.77 2,170,995 D — — (F3) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 4, 2020. (F9) Transaction executed in multiple trades at prices ranging from $149.46 to $150.36 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
7 Common Common Stock 2021-11-09 S D 59,419 $148.81 2,174,795 D — — (F3) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 4, 2020. (F8) Transaction executed in multiple trades at prices ranging from $148.45 to $149.44 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
8 Common Common Stock 2021-11-09 S D 28,946 $148.01 2,234,214 D — — (F3) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 4, 2020. (F7) Transaction executed in multiple trades at prices ranging from $147.44 to $148.43 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
9 Common Common Stock 2021-11-09 S D 12,862 $147.03 2,263,160 D — — (F3) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 4, 2020. (F6) Transaction executed in multiple trades at prices ranging from $146.44 to $147.43 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
10 Common Common Stock 2021-11-09 S D 4,420 $145.81 2,276,022 D — — (F3) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 4, 2020. (F5) Transaction executed in multiple trades at prices ranging from $145.44 to $146.42 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
11 Common Common Stock 2021-11-09 M A 125,000 $2.92 2,283,150 D — — (F1) The stock option exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 4, 2020. (F2) Includes: (i) an annuity distribution on November 5, 2021 of 66,547 shares of the Issuer's Common Stock from the Reporting Person's Grantor Retained Annuity Trust (GRAT), dated May 18, 2020, to the Reporting Person; and (ii) the contribution of 600,000 shares of the Issuer's Common Stock to the creation of three GRATs for the Reporting Person, as described in footnotes 15 and 16 below.
12 Common Common Stock 2021-11-09 S D 2,708 $144.95 2,280,442 D — — (F3) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 4, 2020. (F4) Transaction executed in multiple trades at prices ranging from $144.40 to $145.37 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
13 Derivative Stock Option Grant 2021-11-09 M D 125,000 $0.00 878,457 D $2.92 · — to 2022-12-26 125,000 Common Stock (F17) This option vested 33 1/3% on December 26, 2016 and 8 1/3% per quarter over the subsequent eight quarters.